Pathology and Molecular Biology of Intraductal Papillary Mucinous Neoplasms

  • James G. Kench
  • Peter H. Cosman
  • Neil D. Merrett
  • Andrew V. Biankin
Part of the M. D. Anderson Solid Tumor Oncology Series book series (MDA)

In recent times, the reported incidence of intraductal papillary mucinous neoplasms (IPMN) has increased dramatically. There is no clear reason for this striking increase with some arguing that awareness and recognition of IPMN, improved imaging modalities and an aging population are not sufficient to account for this increase in incidence. Whatever the reason, IPMN now constitute a significant proportion of pancreatic neoplasms worldwide. Key issues in the clinical management of IPMN, including recurrent pancreatitis, the risk of invasive adenocarcinoma and ongoing research, must be underpinned by accurate and reproducible pathological assessment.

IPMN are defined as grossly visible, noninvasive, mucin-producing, predominantly papillary or rarely flat epithelial neoplasms arising from the main pancreatic duct or branch ducts, with varying degrees of duct dilatation. IPMNs usually produce a lesion >1 cm in diameter and include a variety of cell types with a spectrum of cytologic and architectural atypia ( 1 ).


Main Pancreatic Duct Intraductal Papillary Mucinous Neoplasm Branch Duct Intraductal Papillary Mucinous Neoplasm Pancreatic Intraepithelial Neoplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004, 28:977–987.CrossRefPubMedGoogle Scholar
  2. 2.
    Furukawa T, Takahashi T, Kobari M, et al. The mucus-hypersecreting tumor of the pancreas. development and extension visualised by three-dimensional computerised mapping. Cancer 1992, 70:1505–1513.CrossRefPubMedGoogle Scholar
  3. 3.
    Longnecker DS, Hruban RH, Adler G, et al. Intraductal papillary-mucinous neoplasms of the pancreas. In: (Hamilton SR, Aaltonen LA, eds.) WHO classification of tumours. pathology and genetics. Tumours of the digestive system. Lyon, IARC Press, 2000:237–240.Google Scholar
  4. 4.
    Milchgrub S, Campuzano M, Casillas J, et al. Intraductal carcinoma of the pancreas. Cancer 1992, 69:651–656.CrossRefPubMedGoogle Scholar
  5. 5.
    Sho M, Nakajima Y, Kanehiro H, et al. Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas. World J Surg 1998, 22:874–878.CrossRefPubMedGoogle Scholar
  6. 6.
    Kitagawa Y, Unger TA, Taylor S, et al. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg 2003, 7:12–18; discussion 18-19.CrossRefPubMedGoogle Scholar
  7. 7.
    Adsay NV, Conlon KC, Zee SY, et al. Intraductal papillary-mucinous neoplasms of the pan-creas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer 2002, 94:62–77.CrossRefPubMedGoogle Scholar
  8. 8.
    Kench JG, Eckstein RP, Smith RC. Intraductal papillary-mucinous neoplasm of the pancreas: a report of five cases with immunohistochemical findings. Pathology 1997, 29:7–11.CrossRefPubMedGoogle Scholar
  9. 9.
    Solcia E, Capella C, Kloppel G. Tumors of the exocrine pancreas In: Rosai J, Sobin L series editors. Atlas of tumor pathology. Fascicle 20, 3rd series. Tumors of the pancreas. Washington, AFIP 1997, 53–64.Google Scholar
  10. 10.
    Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pan-creas: an updated experience. Ann Surg 2004, 239:788–797; discussion 797-799.CrossRefPubMedGoogle Scholar
  11. 11.
    Adsay NV, Merati K, Iacobuzio-Donahue C, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004, 28:839–848.CrossRefPubMedGoogle Scholar
  12. 12.
    Furukawa T, Kloppel G, Adsay NV, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005, 447:794–799.CrossRefPubMedGoogle Scholar
  13. 13.
    Adsay NV, Adair CF, Heffess CS, et al. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 1996, 20:980–994.CrossRefPubMedGoogle Scholar
  14. 14.
    Warshaw AL. Mucinous cystic tumors and mucinous ductal ectasia of the pancreas. Gastrointest Endosc 1991, 37:199–201.CrossRefPubMedGoogle Scholar
  15. 15.
    Warshaw AL, Compton CC, Lewandrowski K, et al. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg 1990, 212:432–443; discussion 444-445.CrossRefPubMedGoogle Scholar
  16. 16.
    Holme JB, Jacobsen NO, Rokkjaer M, et al. Total pancreatectomy in six patients with intra-ductal papillary mucinous tumour of the pancreas: the treatment of choice. HPB 2001, 3:257–262.Google Scholar
  17. 17.
    Biankin AV, Kench JG, Biankin SA, et al. Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas: implications for disease progression and recurrence. Am J Surg Pathol 2004, 28:1184–1192.CrossRefPubMedGoogle Scholar
  18. 18.
    Longnecker DS, Adsay NV, Fernandez-del Castillo C, et al. Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interob-server agreement. Pancreas 2005, 31:344–349.CrossRefPubMedGoogle Scholar
  19. 19.
    Layfield LJ, Cramer H. Fine-needle aspiration cytology of intraductal papillary-mucinous tumors: a retrospective analysis. Diagn Cytopathol 2005, 32:16–20.CrossRefPubMedGoogle Scholar
  20. 20.
    Frossard JL, Amouyal P, Amouyal G, et al. Performance of endosonography-guided fine nee-dle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol 2003, 98:1516–1524.CrossRefPubMedGoogle Scholar
  21. 21.
    Brandwein SL, Farrell JJ, Centeno BA, et al. Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointest Endosc 2001, 53:722–727.CrossRefPubMedGoogle Scholar
  22. 22.
    Stelow EB, Stanley MW, Bardales RH, et al. Intraductal papillary-mucinous neoplasm of the pancreas. The findings and limitations of cytologic samples obtained by endoscopic ultra-sound-guided fine-needle aspiration. Am J Clin Pathol 2003, 120:398–404.CrossRefPubMedGoogle Scholar
  23. 23.
    Maire F, Couvelard A, Hammel P, et al. Intraductal papillary mucinous tumors of the pan-creas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc 2003, 58:701–706.CrossRefPubMedGoogle Scholar
  24. 24.
    Stelow EB, Bardales RH, Stanley MW. Pitfalls in endoscopic ultrasound-guided fine-needle aspiration and how to avoid them. Adv Anat Pathol 2005, 12:62–73.CrossRefPubMedGoogle Scholar
  25. 25.
    Michaels PJ, Brachtel EF, Bounds BC, et al. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade. Cancer 2006, 108:163–173.CrossRefPubMedGoogle Scholar
  26. 26.
    Emerson RE, Randolph ML, Cramer HM. Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of intraductal papillary mucinous neoplasm of the pancreas is highly predictive of pancreatic neoplasia. Diagn Cytopathol 2006, 34:457–462.CrossRefPubMedGoogle Scholar
  27. 27.
    Couvelard A, Sauvanet A, Kianmanesh R, et al. Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation. Ann Surg 2005, 242:774–778, discussion 778-780.CrossRefPubMedGoogle Scholar
  28. 28.
    Gigot JF, Deprez P, Sempoux C, et al. Surgical management of intraductal papillary mucinous tumors of the pancreas: the role of routine frozen section of the surgical margin, intraoperative endoscopic staged biopsies of the Wirsung duct, and pancreaticogastric anastomosis. Arch Surg 2001, 136:1256–1262.CrossRefPubMedGoogle Scholar
  29. 29.
    Paye F, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery 2000, 127:536–544.CrossRefPubMedGoogle Scholar
  30. 30.
    Biankin AV, Kench JG, Biankin SA, et al. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma. Pathology 2003, 35:14–24.CrossRefPubMedGoogle Scholar
  31. 31.
    Satoh K, Shimosegawa T, Moriizumi S, et al. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas. Pancreas 1996, 12:362–368.CrossRefPubMedGoogle Scholar
  32. 32.
    Biankin AV, Biankin SA, Kench JG, et al. Aberrant p16 INK4A and DPC4/Smad4 expression in intraductal papillary mucinus tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut 2002, 50:861–868.CrossRefPubMedGoogle Scholar
  33. 33.
    Terada T, Ohta T, Nakanuma Y. Expression of oncogene products, anti-oncogene products and oncofetal antigens in intraductal papillary-mucinous neoplasm of the pancreas. Histopathology 1996, 29:355–361.CrossRefPubMedGoogle Scholar
  34. 34.
    Fujii H, Inagaki M, Kasai S, et al. Genetic progression and heterogeneity in intraductal papil-lary-mucinous neoplasms of the pancreas. Am J Pathol 1997, 151:1447–1454.PubMedGoogle Scholar
  35. 35.
    Soldini D, Gugger M, Burckhardt E, et al. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts. J Pathol 2003, 199:453–461.CrossRefPubMedGoogle Scholar
  36. 36.
    Luttges J, Beyser K, Pust S, et al. Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable. Mod Pathol 2003, 16:537–542.CrossRefPubMedGoogle Scholar
  37. 37.
    Inoue H, Tsuchida A, Kawasaki Y, et al. Preoperative diagnosis of intraductal papillary-muci-nous tumors of the pancreas with attention to telomerase activity. Cancer 2001, 91:35–41.CrossRefPubMedGoogle Scholar
  38. 38.
    Niijima M, Yamaguchi T, Ishihara T, et al. Immunohistochemical analysis and in situ hybridi-zation of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas. Cancer 2002, 94:1565–1573.CrossRefPubMedGoogle Scholar
  39. 39.
    Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with con-ventional ductal adenocarcinomas. Am J Pathol 2000, 157:755–761.PubMedGoogle Scholar
  40. 40.
    Hruban RH, Offerhaus GJ, Kern SE, et al. Tumor-suppressor genes in pancreatic cancer. J Hepato-Biliary-Panc Surg 1998, 5:383–391.CrossRefGoogle Scholar
  41. 41.
    Biankin AV, Kench JG, Morey AL, et al. Overexpression of p21 WAF1/CIP1 is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res 2001, 61:8830–8837.PubMedGoogle Scholar
  42. 42.
    Hebrok M, Kim SK, St Jacques B, et al. Regulation of pancreas development by hedgehog signaling. Development 2000, 127:4905–4913.PubMedGoogle Scholar
  43. 43.
    Prasad NB, Biankin AV, Fukushima N, et al. Gene expression profiles in pancreatic intraepi-thelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 2005, 65:1619–1626.CrossRefPubMedGoogle Scholar
  44. 44.
    Thayer SP, Di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pan-creatic cancer tumorigenesis. Nature 2003, 425:851–856.CrossRefPubMedGoogle Scholar
  45. 45.
    Silberg DG, Sullivan J, Kang E, et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2002, 122:689–696.CrossRefPubMedGoogle Scholar
  46. 46.
    Tsukamoto T, Inada K, Tanaka H, et al. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correla-tion during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol 2003, 130:135–145.CrossRefPubMedGoogle Scholar
  47. 47.
    Kim GE, Bae HI, Park HU, et al. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology 2002, 123:1052–1060.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  • James G. Kench
    • 1
    • 2
  • Peter H. Cosman
    • 1
    • 3
  • Neil D. Merrett
    • 3
  • Andrew V. Biankin
    • 1
    • 4
  1. 1.Garvan Institute of Medical ResearchSydney
  2. 2.Institute of Clinical Pathology and Medical ResearchWestmeadAustralia
  3. 3.Bankstown HospitalBankstown, SydneyAustralia
  4. 4.Bankstown HospitalSydneyAustralia

Personalised recommendations